Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 609-612, March 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keightley, D. D.
Right arrow Articles by Okey, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keightley, D. D.
Right arrow Articles by Okey, A. B.

Effect of a Carcinogenic Oral Dose of 7,12-Dimethylbenz(a)anthracene on Receptor Binding of Estradiol-17ß in Uterus and Mammary Tissue throughout Lactation in the Rat1

David D. Keightley and Allan B. Okey2

Department of Biology, University of Windsor, Windsor, Ontario, Canada N9B 3P4

Ingestion of 15 mg of 7,12-dimethylbenz(a)anthracene (DMBA) by lactating Sprague-Dawley rats increased the number of estrogen receptor sites in mammary cytosol fraction and decreased slightly the intrinsic association constant for the estradiol-receptor interaction. These effects were first seen 2 days after treatment, but there were no differences between control and DMBA-treated animals at 20 days after treatment. In the uterus there were no significant differences in the number of binding sites between control and DMBA-treated animals at any point during lactation.

Direct measurements of estradiol-17ß by a radioreceptor assay indicated reduced levels of the endogenous steroid in both mammary gland and uterus following DMBA treatment, but such a reduction could not account for the apparent increase in binding sites in mammary tissue. More likely, there was an increase in the proportion of epithelial cells to fat cells in the mammary glands of DMBA-treated rats, increasing the total amount of estrogen receptor in the gland.

1 This work was supported by Grant A4670 from the National Research Council of Canada.

2 To whom requests for reprints should be addressed.

Received 10/ 9/73. Accepted 12/10/73.




This article has been cited by other articles:


Home page
Toxicol SciHome page
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci., July 1, 2007; 98(1): 5 - 38.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.